Time-critical VA-ECMO-facilitated resuscitation and recovery after acute myocardial infarction with cardiogenic shock and cardiac arrest: a case report Authors: Zhiqiang Wang, Yaliang Tong, Yi Gao, Guohui Liu, Yingying Su, Kenji Wagatsuma, Junru Qu, Beibei Du, Yuquan He Published: 2026 ABSTRACT BackgroundCardiogenic shock (CS) in the setting of acute myocardial infarction (AMI) remains associated with poor prognosis, with mortality of approximately 40%–50% despite mechanical circulatory support (MCS). Its prognostic value remains uncertain because AMI with CS involves complex pathophysiology requiring consideration of implantation timing, organ protection, functional recovery, and prevention of device-related and critical illness-related complications.Case summaryA 36-year-old man with diabetes and hypertension was readmitted with recurrent chest pain 6 months after coronary stent implantation for acute anterior AMI. Initial electrocardiographic findings and rapid hemodynamic deterioration supported AMI complicated by CS. During emergency percutaneous coronary intervention, he developed refractory ventricular fibrillation (VF)/cardiac arrest (CA). Because the arrest occurred under in-hospital monitoring, chest compressions were initiated immediately, resulting in a no-flow interval of 0 min. A multidisciplinary extracorporeal cardiopulmonary resuscitation (ECPR) response was activated, and effective veno-arterial extracorporeal membrane oxygenation (VA-ECMO) flow was established 20 min after activation during ongoing cardiopulmonary resuscitation (CPR). This constituted ECPR rather than VA-ECMO after stable return of spontaneous circulation (ROSC), allowing right coronary artery revascularization with TIMI grade 3 flow. After VA-ECMO initiation, the early post-resuscitation course was complicated by weak arterial pulsatility, restricted aortic valve opening, persistent hyperlactatemia, pneumonia/airway infection, transient hyperosmolar disturbance, and suspected post-arrest hypoxic-ischemic encephalopathy. With multidisciplinary management, cardiac function improved, organ dysfunction partially recovered, and the patient was discharged on day 10 with a favorable neurological outcome, defined as Cerebral Performance Category (CPC) grade 1 and modified Rankin Scale (mRS) score 0. At 1 year, follow-up confirmed sustained functional recovery, patent previous stenting without significant restenosis, no progression of other coronary lesions, return to normal quality of life, and persistently favorable neurological status (CPC 1; mRS 0).ConclusionThis case highlights the value of program-level ECPR readiness in selected patients with monitored AMI-related refractory CA during emergency percutaneous coronary intervention. A pre-primed ECMO pathway, immediate CPR, 0 min no-flow exposure, 20 min ECPR activation-to-flow interval, completed coronary reperfusion, and complication-focused multidisciplinary care contributed to this outcome. As a single case, these findings should be interpreted as hypothesis-generating rather than supporting unselective VA-ECMO use in AMI complicated by CS. Introduction Cardiac arrest (CA) occurring during emergency percutaneous coronary intervention for acute myocardial infarction (AMI) represents a time-critical and technically challenging scenario. Ongoing cardiopulmonary resuscitation (CPR) may compromise procedural stability, coronary visualization, and systemic perfusion, whereas prolonged low-flow exposure is associated with poor neurological and survival outcomes (1). In selected patients with refractory CA, extracorporeal cardiopulmonary resuscitation (ECPR) may provide temporary circulatory support and create a hemodynamic window for definitive coronary reperfusion (1). This distinction is important in a case report, because ECPR for refractory arrest during ongoing CPR differs clinically and conceptually from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock (CS) after stable return of spontaneous circulation (ROSC). The central teaching point of this case is that, in monitored AMI-related refractory CA during emergency percutaneous coronary intervention, a pre-primed extracorporeal membrane oxygenation (ECMO) pathway and coordinated institutional readiness may minimize no-flow and low-flow exposure and create a hemodynamic window for completion of coronary reperfusion. Case presentation A 36-year-old overweight man with diabetes mellitus, hypertension, and a prior smoking history presented with recurrent chest discomfort that had worsened during the preceding 2 h. Six months earlier, he had undergone left anterior descending artery stenting for acute anterior myocardial infarction at another hospital and was prescribed dual antiplatelet therapy with aspirin 100 mg once daily and ticagrelor 90 mg twice daily. After discharge, he independently discontinued aspirin and ticagrelor without medical advice. At presentation, he appeared lethargic and showed signs of peripheral hypoperfusion. Physical examination revealed bilateral coarse breath sounds with diffuse moist rales, attenuated heart sounds, limb cyanosis, a blood pressure of 80/60 mmHg, and a heart rate of 120 beats/min. The initial electrocardiogram demonstrated inferior-lead ST-segment elevation (Figure 1A), supporting the diagnosis of AMI. Laboratory testing showed cardiac troponin I 7.300 μg/L, myoglobin >900.0 μg/L, creatine kinase-MB 431.0 μg/L, D-dimer 3,530.0 μg/L, and no elevation of N-terminal pro-B-type natriuretic peptide. Norepinephrine was started after AMI with CS was diagnosed, with only modest hemodynamic improvement. ECG and primary percutaneous coronary intervention findings. (A) ECG demonstrating ST-segment elevation with T-wave inversion in leads II, III, and aVF, together with reciprocal ST depression in leads I and aVL, mainly reflecting right coronary artery occlusion. (B) Baseline angiography showing total proximal RCA occlusion with a large thrombus burden and TIMI 0 flow. (C) Guidewire passage and thrombus aspiration. (D) Stent deployment in the mid RCA. (E) Final angiography showing restored TIMI grade 3 flow in the RCA. (F) Normal stent in the mid LAD. (G) Small-caliber left circumflex artery (LCX) with 80%–90% distal stenosis and preserved distal flow. ECG, electrocardiogram; RCA, right coronary artery; LAD, left anterior descending artery; LCX, left circumflex artery. Twenty-eight minutes after arrival, the patient developed ventricular fibrillation (VF) in the emergency department at 01:33. Chest compressions were initiated immediately, resulting in a no-flow interval of 0 min. Sinus rhythm with ROSC was achieved after two external defibrillation attempts combined with high-quality manual CPR. The patient was then transferred for emergency coronary angiography. Femoral access was obtained 38 min after admission, and coronary angiography identified acute thrombotic occlusion of the right coronary artery (Figure 1B). During angiography, VF recurred and progressed to CA at 01:50. Chest compressions were restarted immediately. Despite 16 unsynchronized 360-J defibrillation attempts (Figure 2A), rhythm conversion was unsuccessful, consistent with refractory VF/CA. During advanced cardiac life support, epinephrine 1 mg was administered every 3 min for six doses, with a total dose of 6 mg, and atropine 1 mg was administered every 5 min for three doses, with a total dose of 3 mg. No antiarrhythmic drug was administered. Dopamine infusion, prepared at 0.8 mg/mL, was initiated at 30 mL/h for vasopressor support. No transient ROSC occurred before effective ECMO flow was established. After family consent, the patient underwent tracheal intubation, mechanical ventilation, sedation, analgesia, and neuromuscular blockade. End-tidal carbon dioxide monitoring was not performed during resuscitation. Manual CPR was continued without interruption during cannulation. A multidisciplinary ECPR response involving ultrasonography, anesthesiology, ECMO nursing, and interventional cardiology was activated at 01:52. A pre-primed VA-ECMO circuit was inserted under ultrasound guidance, cannulation was completed at 02:05, and effective VA-ECMO flow of 3.0 L/min/m2 was established at 02:12. Because there was no sustained ROSC before ECMO flow was established, VA-ECMO was initiated as ECPR during ongoing manual CPR. The ECPR activation-to-flow interval, defined as the time from multidisciplinary ECPR response activation to effective ECMO flow, was 20 min, with ongoing manual CPR during this period. Management during the acute in-hospital phase. (A) Skin with clear defibrillator-pad impressions, surrounding erythema, and singed body hair after 16 defibrillations during CPR for cardiac arrest in the catheterization laboratory. (B) The immediate post-procedural course included severe hyperlactatemia (>15 mmol/L) and hypotension (SBP 79 mmHg, PP 14 mmHg, MAP 70 mmHg). After VA-ECMO support, blood pressure improved and lactate decreased at 6 h after the procedure (3.8 mmol/L, SBP 93 mmHg, PP 10 mmHg, MAP 86 mmHg). By post-procedural day 3, blood pressure had normalized and lactate had fallen markedly (1.7 mmol/L, SBP 123 mmHg, PP 31 mmHg, MAP 102 mmHg). (C) Arrow indicating obvious bite marks on the endotracheal tube, suggesting impaired airway ventilation. (D) Post-procedural hyperosmolar state (plasma osmolality 328.53 mOsm/kg·H2O, serum sodium 150.6 mmol/L), which worsened to a peak at 34 h after the procedure (342.74 mOsm/kg·H2O, 157.9 mmol/L). Treatment stabilized the parameters by 64 h after the procedure (315.92 mOsm/kg·H2O, 144.0 mmol/L), with normalization at 88 h after the procedure (309.36 mOsm/kg·H₂O, 140.9 mmol/L). CPR, cardiopulmonary resuscitation; SBP, systolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; VA-ECMO, veno-arterial extracorporeal membrane oxygenation. After effective ECMO flow was established and systemic pressure stabilized, the cardiac rhythm was characterized by a wide QRS complex, and coronary intervention was completed. Angiography confirmed a substantial thrombotic burden within the right coronary artery (Figure 1B). The guidewire crossed the culprit right coronary artery lesion at 02:12 (Figure 1C). The lesion was treated with balloon predilation at 02:23, intracoronary tirofiban 0.5 mg at 02:35, percutaneous coronary thrombectomy at 02:46, intracoronary nitroprusside 100 μg at 02:57, and stent deployment at 03:09 to improve distal microvascular flow. TIMI grade 3 flow was restored at 03:20 (Figures 1D,E). Left coronary angiography showed no critical stenosis of the left main artery or the previously stented left anterior descending artery (Figure 1F), whereas the distal left circumflex artery was small in caliber and had 80%–90% stenosis (Figure 1G). On the basis of these angiographic findings, the recurrent infarction was considered more likely related to acute thrombotic occlusion of the right coronary artery than to angiographically evident in-stent restenosis or thrombosis of the previously treated left anterior descending artery. The severe distal left circumflex lesion also indicated multivessel coronary disease and raised concern for premature or rapidly progressive atherosclerosis. Given the patient's young age, recurrent myocardial infarction within 6 months, and multivessel coronary disease, premature or rapidly progressive atherosclerosis was considered clinically important. Familial hypercholesterolemia, lipoprotein(a) elevation, and drug discontinuation were considered as potential contributors; however, a complete etiological workup was not completed during the index hospitalization because of the time-critical arrest, ECPR, and acute critical-care course. Outpatient evaluation for these risk factors was recommended, together with strict adherence to dual antiplatelet therapy and intensive lipid-lowering therapy. A detailed minute-by-minute resuscitation and reperfusion timeline is provided in Figure 3. The patient was then transferred to the CCU for intensive post-procedural care. Timeline of resuscitation, ECPR, coronary reperfusion, and in-hospital course. The no-flow interval was 0 min, and the ECPR activation-to-flow interval was 20 min. VF, ventricular fibrillation; CA, cardiac arrest; CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; ED, emergency department; CATH LAB, catheterization laboratory; CAG, coronary angiography; PCI, percutaneous coronary intervention; ECMO, extracorporeal membrane oxygenation; VA-ECMO, veno-arterial extracorporeal membrane oxygenation; ECPR, extracorporeal cardiopulmonary resuscitation; MDT, multidisciplinary team; GW, guidewire; RCA, right coronary artery; IC, intracoronary; Tiro, tirofiban; SNP, sodium nitroprusside; Epi, epinephrine; DA, dopamine; IABP, intra-aortic balloon pump; CCU, coronary care unit; IMV, invasive mechanical ventilation; POD, post-procedural day; TIMI, Thrombolysis in Myocardial Infarction. Post-procedural anticoagulation was started with low-molecular-weight heparin administered subcutaneously at 5,000 IU every 12 h. Initial arterial blood gas analysis after transfer showed severe metabolic acidosis with lactate exceeding 15 mmol/L. Hemodynamic targets were maintained with a mean arterial pressure of approximately 70 mmHg and a pulse pressure of 14 mmHg (Figure 2B). Supportive therapy included sodium bicarbonate for acidosis, midazolam and dexmedetomidine for sedation, remifentanil for analgesia, norepinephrine and dopamine for circulatory support, esomeprazole for gastrointestinal protection, and regular airway suctioning. Electrolyte status and myocardial recovery were reassessed serially. Six hours after percutaneous coronary intervention and VA-ECMO initiation, acidosis had improved, lactate had fallen to 3.8 mmol/L, and mean arterial pressure had increased to 86 mmHg (Figure 2B). Echocardiography demonstrated diffuse left ventricular wall-motion abnormality, severe systolic dysfunction with left ventricular ejection fraction (LVEF) 15% (Figure 4), and left ventricular end-diastolic diameter (LVDd) 49.5 mm (Figure 4). Guideline-directed medical therapy combined with recombinant human brain natriuretic peptide was then introduced for heart failure. Recovery of cardiac function during the first postoperative year. Bedside echocardiography showed LVEF 15% and LVDd 49.5 mm on the procedure day. After standard anti-heart failure treatment and therapy aimed at improving myocardial remodeling, LVEF increased to 49% on post-procedural day 7, 60% at the 3-month follow-up, and 61% at the 1-year follow-up. LVDd decreased to 42.0 mm on post-procedural day 3 and remained approximately 41.4 mm during subsequent follow-up. LVEF, left ventricular ejection fraction; LVDd, left ventricular end-diastolic diameter. During VA-ECMO support, left ventricular distension and stasis were monitored using arterial pressure waveforms, pulse pressure, serial bedside echocardiography, aortic valve opening, LVDd, left ventricular systolic function, and clinical evidence of pulmonary congestion. On post-procedural day 1, echocardiography showed inadequate aortic valve opening, raising concern for left ventricular stasis under VA-ECMO support. Laboratory reassessment 34 h after the procedure showed peak hyperosmolarity, with plasma osmolality of 342.74 mOsm/kg·H₂O and serum sodium of 157.9 mmol/L (Figure 2D). LVEF had improved to 29% (Figure 4), but persistent restriction of aortic valve opening, together with weak arterial pulsatility, prompted intra-aortic balloon pump (IABP) insertion for ventricular unloading and augmentation of coronary perfusion. IABP was selected as the unloading strategy because left ventricular function was already improving and the anticipated unloading requirement was considered potentially manageable with IABP support. Further unloading strategies, such as Impella support or atrial septostomy, were not pursued at that stage because systemic pressure and pulsatility improved after IABP initiation. After IABP support was added, systolic pressure increased to 107 mmHg, mean arterial pressure increased to 92 mmHg, and pulse pressure increased to 23 mmHg (Figure 2B). Supportive care included gastrointestinal protection, enteral nutrition, liver-protective therapy, and targeted antimicrobial therapy with meropenem for Streptococcus pneumoniae pneumonia/airway infection. On post-procedural day 2, LVEF had increased to 42% (Figure 4), suggesting improvement in cardiac function, and vital signs remained stable. IABP support was therefore stepped down from 1:1 to 1:2 assistance and then reduced stepwise without hemodynamic compromise. VA-ECMO flow was reduced to less than 1.5 L/min/m2 while vasoactive drug requirements decreased, and VA-ECMO support was successfully discontinued on post-procedural day 2 after a total support duration of 66 h. Decannulation was performed on post-procedural day 2 without major vascular complications. The patient remained hemodynamically stable after weaning from VA-ECMO. IABP support was maintained for 33 h and was removed successfully on post-procedural day 3. On post-procedural day 3, LVEF reached 45.4%. As midazolam and dexmedetomidine were gradually reduced, fever and infectious signs emerged, and the patient became agitated enough to bite through the endotracheal tube (Figure 2C); difficulty advancing the suction catheter during routine suctioning suggested sputum-plug airway obstruction, so blood cultures and pathogen testing were obtained, and fiberoptic bronchoscopy followed by re-intubation was performed in collaboration with the respiratory and critical care teams, after which blood cultures were negative, no clinical evidence of cannula-related infection was found, and infection-related findings improved. Enteral free-water administration via the gastric tube over 2 days improved the hyperosmolar disturbance, with plasma osmolality decreasing to 315.92 mOsm/kg·H2O and serum sodium to 144.0 mmol/L (Figure 2D). Respiratory status subsequently stabilized, allowing extubation on post-procedural day 4 after a total invasive mechanical ventilation duration of 118 h, followed by transition to non-invasive ventilatory support with peripheral oxygen saturation maintained above 95%. After sedatives were discontinued, neurological recovery was characterized by apathy and psychomotor slowing. On day 5, LVEF increased to 46.7% (Figure 4). High-flow non-invasive humidification therapy was initiated, and oxygen support was gradually reduced to nasal cannula oxygen. The patient showed persistent purposeless and stereotyped behaviors accompanied by speech abnormalities. Neurological assessment during this stage showed impaired consciousness and abnormal behavior, without definite focal neurological deficits on bedside examination. Because neurological recovery remained slower than expected, a multidisciplinary assessment involving neurology, critical care medicine, and rehabilitation was performed on day 6. According to the patient's condition, head and chest CT scans were obtained. Head CT showed bilateral basal ganglia lacunar infarcts, whereas electroencephalography showed no epileptiform activity or other evidence suggesting an alternative primary neurological cause. Serum neuron-specific enolase was not measured. Based on the clinical course, delayed awakening, transient neurobehavioral abnormalities, and exclusion of alternative primary neurological causes, the neurological syndrome was interpreted as suspected post-arrest hypoxic-ischemic encephalopathy rather than imaging-confirmed structural hypoxic-ischemic brain injury. Supportive neurorehabilitative treatment included mannitol injection, targeted brain protection, rehabilitation training, hyperbaric oxygen therapy, and regular rehabilitation acupuncture. By day 7, LVEF had improved to 49% (Figure 4), with no obvious major systemic sequelae at that time. Because the reduced LVEF after myocardial infarction was considered post-infarction heart failure, guideline-directed medical therapy for heart failure was initiated, including metoprolol, spironolactone, dapagliflozin, sacubitril/valsartan, and vericiguat. Rosuvastatin and ezetimibe were prescribed for intensive lipid lowering as part of secondary prevention. After 5 days of supportive neurorehabilitative treatment, neurological status improved markedly. The patient was discharged home on hospital day 10 in stable condition with a favorable neurological outcome, with CPC 1 and mRS 0. The CCU length of stay was 5 days. At discharge, the most recent LVEF was 49% on post-procedural day 7 (Figure 4), serum lactate was 1.7 mmol/L, serum creatinine was 57.3 μmol/L, the ALT-to-AST ratio was 1.25, serum sodium was 138.1 mmol/L, and plasma osmolality was 290.78 mOsm/kg·H2O. He was receiving low-flow oxygen through a nasal cannula at 2 L/min, with stable hemodynamics and no requirement for vasoactive support. At 1 month after discharge, tafolecimab 150 mg administered subcutaneously every 2 weeks was added for intensive lipid lowering. At 3 months, repeat electrocardiogram and echocardiography at a local hospital showed LVEF 60% (Figure 4). At 1 year after discharge, repeat inpatient coronary angiography confirmed that the original stent was normal and that other lesions had not progressed. Repeat echocardiography showed recovery of cardiac function with LVEF 61% and reverse cardiac remodeling with LVDd 41.4 mm (Figure 4). pro-B-type natriuretic peptide was not elevated, and there were no abnormalities in limb sensation or motor function. The patient reported no marked chest tightness or dyspnea during physical activity, brisk walking, or stair climbing. Recent body weight had increased by approximately 10 kg compared with the previous hospitalization. Neurological functional outcome remained favorable at follow-up (CPC 1; mRS 0). Discussion This case describes recovery after AMI-related refractory VF/CA during coronary angiography. The key clinical sequence was rapid transition from conventional CPR to ECPR using a pre-primed VA-ECMO pathway, which created a temporary hemodynamic window for completion of right coronary artery revascularization and initiation of post-arrest organ support. The favorable course should be interpreted as multifactorial rather than as the effect of VA-ECMO alone. Important contributors included the patient's young age, monitored in-hospital arrest, a no-flow interval of 0 min, rapid ECPR activation, a 20 min ECPR activation-to-flow interval during ongoing CPR, timely restoration of TIMI grade 3 flow, and availability of an experienced multidisciplinary ECMO pathway. Because neurological recovery is central to the evaluation of ECPR success, Cerebral Performance Category and modified Rankin Scale were recorded at discharge and follow-up, and both indicated preserved neurological function at both time points. The contemporary evidence base for temporary mechanical circulatory support (MCS) in AMI complicated by CS is heterogeneous and should be interpreted according to device type, timing, and patient phenotype (2). Meta-analytic data in ST-segment elevation myocardial infarction complicated by CS have also emphasized the importance of patient selection and complication awareness when VA-ECMO is used (3). IABP-SHOCK II did not demonstrate a mortality benefit from routine IABP use in AMI complicated by CS (4). Similarly, ECLS-SHOCK did not show a reduction in the primary endpoint of 30-day mortality with early routine extracorporeal life support/VA-ECMO in patients with infarct-related CS; secondary endpoints were not significantly improved, and bleeding and peripheral vascular complications were more frequent in the extracorporeal life support group (5). In contrast, DanGer Shock suggested that Impella-based unloading may reduce mortality in selected patients with ST-segment elevation myocardial infarction-related CS, although device-related adverse events were more frequent (6, 7). These trials do not support unselective VA-ECMO use for all patients with AMI complicated by CS but instead emphasize the importance of patient selection, device selection, and timing. Importantly, the present case is better framed within the ECPR literature than within the literature on medically stabilizable CS alone. The patient developed monitored refractory VF/CA during coronary angiography, and VA-ECMO was established during ongoing CPR rather than after stable ROSC. Randomized ECPR studies have yielded heterogeneous results, with ARREST showing benefit in selected refractory VF arrest (8), whereas Prague OHCA and INCEPTION were neutral (9, 10). These findings suggest that ECPR outcomes are highly dependent on witnessed or monitored arrest, rapid team activation, short no-flow and low-flow intervals, and the ability to treat the reversible cause. This single case is therefore hypothesis-generating and should not be extrapolated to support unselective VA-ECMO use in AMI complicated by CS. Time to effective circulatory support is one of the few modifiable variables during AMI complicated by CS and CA. Prolonged CPR markedly reduces the probability of neurologically intact survival; reported data show that after 20 min of CPR following CS and CA, the rate of favorable neurological outcome at 1 month decreases from 21.8% to 1.9%, and after 30 min, it decreases further to 0.4% (11). When extracorporeal support is selected, the operational goal is therefore to compress the interval between CPR initiation, cannulation, and achievement of adequate flow, thereby limiting cerebral hypoperfusion and secondary organ failure (12). Observational studies have also linked shorter CA-to-ECMO or door-to-implantation intervals with improved survival or neurological outcomes in patients receiving ECPR (13–15). In the present case, effective VA-ECMO flow was established 20 min after ECPR activation during ongoing CPR. This timing may have contributed to recovery, but its effect cannot be isolated from simultaneous favorable conditions, including immediate CPR, a no-flow interval of 0 min, short CPR-supported low-flow exposure, and rapid revascularization. Later improvement in left ventricular ejection fraction and reverse remodeling probably reflected the combined effects of reperfusion, hemodynamic stabilization, optimized heart failure therapy, and secondary prevention. Cannulation during CS or CA is technically demanding because profound hypotension, absent pulsatility, or ongoing CPR may obscure vascular landmarks and increase the risk of access-related injury. Ultrasound-guided femoral access is therefore important not only for procedural safety but also for reducing delay to effective support (16). The feasibility of timely VA-ECMO deployment depends on institutional logistics as much as operator skill, including circuit readiness, trained cannulators, coordinated emergency-department workflow, and immediate critical-care integration; procedural volume and institutional experience have also been associated with outcomes in patients receiving VA-ECMO support (17–19). These requirements support the development of dedicated ECMO response pathways for patients with AMI-CS who deteriorate into CA. Post-ECPR management was essential to the favorable course, because patients receiving VA-ECMO for CS or CA remain vulnerable to device-related and critical illness-related complications (20). Retrograde arterial flow during peripheral VA-ECMO can increase left ventricular afterload, raise end-diastolic pressure, promote pulmonary congestion, and predispose to intracardiac stasis, particularly when aortic valve opening is limited (21, 22). In this patient, weak arterial pulsatility and restricted aortic valve opening were treated as warning signs of left ventricular stasis. Serial hemodynamic and echocardiographic assessment guided the decision to add IABP support for unloading and coronary perfusion augmentation (23). The subsequent increase in pulse pressure and progressive recovery of left ventricular systolic function suggested that this strategy was sufficient in this patient. Other unloading approaches, including Impella support or atrial septostomy, may be appropriate in patients with persistent left ventricular distension, pulmonary edema, or intracardiac stasis despite initial measures. Observational studies and meta-analytic data have suggested that concomitant IABP support during VA-ECMO may be associated with improved outcomes in AMI complicated by CS, although these data remain non-randomized and should be interpreted cautiously (24, 25). Neurological recovery was interpreted cautiously, particularly because low pulsatility during VA-ECMO has been associated with acute brain injury (26). Because CT did not confirm diffuse acute hypoxic-ischemic injury and electroencephalography did not show epileptiform activity, the delayed awakening and transient neurobehavioral abnormalities were described as suspected post-arrest hypoxic-ischemic encephalopathy rather than imaging-confirmed structural hypoxic-ischemic brain injury. Serum neuron-specific enolase was not measured (27). Supportive care included serial clinical assessment, mannitol-based osmotherapy, brain-protective care, and rehabilitation-based interventions. Hyperbaric oxygen therapy and acupuncture were used as adjunctive supportive measures and should not be interpreted as evidence of proven disease-modifying efficacy. Overall, this case supports early recognition and targeted management of post-ECPR complications within a coordinated cardiac critical-care system, but the favorable outcome remains hypothesis-generating. Conclusion This case illustrates that favorable recovery is possible in selected patients with monitored AMI-related refractory VF/CA when immediate CPR, rapid ECPR using a pre-primed VA-ECMO pathway, prompt coronary reperfusion, and early management of key complications are achieved. In this patient, the no-flow interval was 0 min, effective VA-ECMO flow was established 20 min after ECPR activation during ongoing CPR, and percutaneous coronary intervention restored TIMI grade 3 flow. Because this is a single case, the favorable outcome should be interpreted cautiously and should not be extrapolated to support unselective VA-ECMO use in AMI complicated by CS.